News Roundup [abridged Versions Appear In The Paper Journal]

US agency wants to limit lawsuits against drug manufacturers

BMJ 2006; 332 doi: https://doi.org/10.1136/bmj.332.7535.196-d (Published 26 January 2006) Cite this as: BMJ 2006;332:196
  1. Jeanne Lenzer
  1. New York

    The US Food and Drug Administration has issued a policy statement that will make it harder for people to sue drug manufacturers. The statement, supporting an arrangement known as “pre-emption,” was inserted into the agency's new guidelines on drug labelling. It asserts that complying with the FDA's labelling requirements should preempt or supersede individual states' liability statutes.

    The new statement means that, in the FDA's opinion, as long as a drug company complies with federal labelling laws, the company should not be found in violation of statutes on “failure to warn.” The statement does not have the force of law but may be considered by the courts.

    The statement sparked an angry reaction from Edward Kennedy, the Democrat senator for Massachusetts. “It's a typical abuse by the Bush administration: take a regulation to improve the information that doctors and patients receive about prescription drugs and turn it into …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial

    Subscribe